US PHARMACEUTICAL giant Eli Lilly announced today it was cutting the cost of its most commonly prescribed insulins by 70% after years of soaring prices that hit millions of Americans living with diabetes.
The announcement comes as the cost of insulin has surged in recent years, with demand increasing significantly as well.